(Albany, US) DelveInsight has launched a new report on Stargardt Disease Market Insights, Epidemiology and Market Forecast-2030
DelveInsight’s “Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Stargardt Disease , historical and forecasted epidemiology as well as the Stargardt Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Stargardt Disease market report provides current treatment practices, emerging drugs, Stargardt Disease (STGD) market share of the individual therapies, current and forecasted Stargardt Disease (STGD) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Stargardt Disease (STGD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Stargardt disease (STGD) is named after Karl Stargardt, a German ophthalmologist who first reported a case in his practice in 1901. It is also called Stargardt macular dystrophy, juvenile macular degeneration, or fundus flavimaculatus. It is a rare retinal disorder inherited in an autosomal recessive pattern. Decreased central vision due to loss of photoreceptors in the macula is the hallmark of Stargardt disease. It typically develops during childhood or adolescence, but the age of onset and rate of progression can vary.
Request for:- Stargardt Disease free sample page
Stargardt Disease Epidemiology
The Stargardt Disease (STGD) epidemiology division provide insights about historical and current Stargardt Disease (STGD) patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Report Key Facts :-
1. According to the estimates provided by National Institute for Health, the reported prevalence of Stargardt disease is estimated to be 1 in 8,000 to 10,000 individuals.
2. According to American Institute of Ophthalmology, STGD is the most commonly inherited childhood and adulthood maculopathy and has a prevalence of 1 in 10,000.
Report key stregths
Table of Content
1. Key Insights
2. Executive Summary of Stargardt Disease (STGD)
3. Competitive Intelligence Analysis for Stargardt Disease (STGD)
4. Stargardt Disease (STGD) : Market Overview at a Glance
4.1. Stargardt Disease (STGD) Total Market Share (%) Distribution in 2017
4.2. Stargardt Disease (STGD) Total Market Share (%) Distribution in 2030
5. Stargardt Disease (STGD) : Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Stargardt Disease (STGD) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Stargardt Disease (STGD) Treatment and Management
8.2. Stargardt Disease (STGD) Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Stargardt Disease (STGD) Treatment
11. Marketed Products
12. Emerging Therapies
13. Stargardt Disease (STGD) : Seven Major Market Analysis
13.1. Key Findings
13.2. Stargardt Disease (STGD) Market Size in 7MM
13.3. Stargardt Disease (STGD) Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Stargardt Disease (STGD)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report ?
Related Reports:-
1. Stargardt Disease (STGD) – Epidemiology Forecast to 2030
2. Stargardt Disease (STGD) – Pipeline Insights, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/